A carregar...
Titin mutation associated with responsiveness to checkpoint blockades in solid tumors
Immune checkpoint blockade (ICB) immunotherapy induces potent antitumor immunity across multiple solid tumors, although few patients respond well to this therapy. An emerging biomarker for predicting responsiveness to ICB immunotherapy is tumor mutational burden (TMB). Although several surrogate bio...
Na minha lista:
| Publicado no: | JCI Insight |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6542599/ https://ncbi.nlm.nih.gov/pubmed/31092729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.127901 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|